These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 1320362

  • 61. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. In vitro activity of lomefloxacin (NY-198 or SC 47111).
    Shah PM, Müller S, Kipp J, Stille W.
    Diagn Microbiol Infect Dis; 1989 Sep; 12(3 Suppl):97S-101S. PubMed ID: 2791506
    [Abstract] [Full Text] [Related]

  • 64. In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.
    Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1990 Feb; 34(2):306-13. PubMed ID: 2327779
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria.
    Cohen MA, Huband MD, Mailloux GB, Yoder SL, Roland GE, Heifetz CL.
    Diagn Microbiol Infect Dis; 1991 Feb; 14(5):403-15. PubMed ID: 1665775
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Louie A, Baltch AL, Ritz WJ, Smith RP.
    Chemotherapy; 1991 Feb; 37(4):275-82. PubMed ID: 1665123
    [Abstract] [Full Text] [Related]

  • 73. In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.
    Akaniro JC, Stutman HR, Arguedas AG, Vargas OM.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):255-61. PubMed ID: 1318674
    [Abstract] [Full Text] [Related]

  • 74. In vitro activity of sparfloxacin (AT-4140 and CI-978), a new quinolone antimicrobial agent, against Haemophilus and gram-positive cocci.
    Rudrik JT, Ferrigno SR, Gee SL.
    Diagn Microbiol Infect Dis; 1991 Feb; 14(4):355-60. PubMed ID: 1889186
    [Abstract] [Full Text] [Related]

  • 75. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
    Bongaerts GP, Hoogkamp-Korstanje JA.
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2017-9. PubMed ID: 8239624
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Antibacterial activity of lomefloxacin.
    Leigh DA, Tait S, Walsh B.
    J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.